We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Hologic Inc | NASDAQ:HOLX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.27 | 0.36% | 75.98 | 75.52 | 76.54 | 76.61 | 75.14 | 75.23 | 919,462 | 01:00:00 |
BEDFORD, Mass., April 9, 2014 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, today announced plans to release its second quarter fiscal 2014 operating results on Wednesday, April 30, 2014, after market close. In conjunction with the release, management will host a conference call on Wednesday, April 30, 2014, at 5:00 p.m. (Eastern).
Interested participants may listen to the call by dialing 877-856-1955 or 719-325-4807 for international callers and referencing participant code 9333157 approximately 15 minutes prior to the call. For those unable to participate in the live broadcast, a replay will be available two hours after the call ends through Friday, May 23, 2014, at 888-203-1112 or 719-457-0820 for international callers, access code 9333157.
The Company will also provide a live webcast of the call. Interested participants may access the webcast on the Company's website at http://investors.hologic.com/investors-overview. A replay of the call will be archived on the Company's website and a PowerPoint presentation related to the conference call will be posted to the site after market close on Wednesday, April 30, 2014.
About Hologic, Inc.:
Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products, with an emphasis on serving the healthcare needs of women. The Company operates four core business units focused on breast health, diagnostics, GYN surgical and skeletal health. With a comprehensive suite of technologies and a robust research and development program, Hologic is committed to improving lives. The Company is headquartered in Massachusetts. For more information, visit www.hologic.com.
Contacts: | |
Deborah R. Gordon |
Al Kildani |
Vice President, Investor Relations and Corporate Communications |
Senior Director, Investor Relations |
(781) 999‐7716 |
(858) 410‐8653 |
deborah.gordon@hologic.com |
al.kildani@hologic.com |
SOURCE Hologic, Inc.
Copyright 2014 PR Newswire
1 Year Hologic Chart |
1 Month Hologic Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions